Nanoformulations targeting immune cells for cancer therapy: mRNA therapeutics
The approved worldwide use of two messenger RNA (mRNA) vaccines (BNT162b2 and mRNA-1273) in late 2020 has proven the remarkable success of mRNA therapeutics together with lipid nanoformulation technology in protecting people against coronaviruses during COVID-19 pandemic. This unprecedented and exci...
Guardat en:
| Autors principals: | , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
KeAi Communications Co., Ltd.
2023-05-01
|
| Col·lecció: | Bioactive Materials |
| Matèries: | |
| Accés en línia: | http://www.sciencedirect.com/science/article/pii/S2452199X22004789 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|